CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Total cash, cash equivalents, and restricted cash	$ 23,190	$ 25,110	$ 25,340
Cash flows from operating activities
Net income/(loss)	5,894	4,329	(2,152)
Depreciation and tooling amortization	7,567	7,690	7,642
Other amortization	(1,700)	(1,167)	(1,149)
Provision for credit and insurance losses	575	438	46
Pension and Other Postretirement Employee Benefits (OPEB) expense/(income)	149	3,052	(378)
Equity method investment (earnings)/losses and impairments in excess of dividends received	(287)	(33)	3,324
Foreign currency adjustments	227	(234)	(27)
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	42	205	7,518
Stock compensation (Note 6)	511	460	336
Provision for deferred income taxes	350	(1,649)	(1,910)
Increase (Decrease) in Finance Receivables	(4,299)	(4,827)	(10,560)
Decrease/(Increase) in accounts receivable and other assets	(2,497)	(2,620)	(1,183)
Decrease/(Increase) in inventory	27	(1,219)	(2,576)
Increase/(Decrease) in accounts payable and accrued and other liabilities	8,425	9,829	7,268
Other Operating Activities, Cash Flow Statement	439	664	654
Net cash provided by/(used in) operating activities	15,423	14,918	6,853
Cash flows from investing activities
Capital spending	(8,684)	(8,236)	(6,866)
Acquisitions of finance receivables and operating leases	(59,720)	(54,505)	(45,533)
Collections of finance receivables and operating leases	45,159	44,561	46,276
Proceeds from sale of business	0	0	449
Payments to Acquire Marketable Securities	(12,300)	(8,590)	(17,458)
Sales and maturities of marketable securities and other investments	12,346	12,700	19,117
Settlements of derivatives	(268)	(138)	94
Capital contributions to equity method investments	(2,323)	(2,733)	(738)
Proceeds from Equity Method Investment, Distribution, Return of Capital	1,465	1	0
Other	(45)	(688)	312
Net Cash Provided by (Used in) Investing Activities	(24,370)	(17,628)	(4,347)
Cash flows from financing activities
Cash payments for dividends and dividend equivalents	(3,118)	(4,995)	(2,009)
Purchases of common stock	(426)	(335)	(484)
Net changes in short-term debt	(276)	(1,539)	5,460
Proceeds from Issuance of Long-Term Debt	57,312	51,659	45,470
Repayments of Long-Term Debt	(45,680)	(41,965)	(45,655)
Other	(327)	(241)	(271)
Net Cash Provided by (Used in) Financing Activities	7,485	2,584	2,511
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(458)	(104)	(414)
Cash, cash equivalents, and restricted cash at beginning of period (Note 9)	25,110	25,340	20,737
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(1,920)	(230)	4,603
Cash, cash equivalents, and restricted cash at end of period (Note 9)	$ 23,190	$ 25,110	$ 25,340